Published in Infect Immun on July 01, 2005
Roles of macrophages and neutrophils in the early host response to Bacillus anthracis spores in a mouse model of infection. Infect Immun (2006) 1.93
Capsules, toxins and AtxA as virulence factors of emerging Bacillus cereus biovar anthracis. PLoS Negl Trop Dis (2015) 1.51
Inflammasome sensor Nlrp1b-dependent resistance to anthrax is mediated by caspase-1, IL-1 signaling and neutrophil recruitment. PLoS Pathog (2010) 1.39
Murine aerosol challenge model of anthrax. Infect Immun (2007) 1.30
Bacillus anthracis spores and lethal toxin induce IL-1beta via functionally distinct signaling pathways. Eur J Immunol (2008) 1.27
The germination-specific lytic enzymes SleB, CwlJ1, and CwlJ2 each contribute to Bacillus anthracis spore germination and virulence. J Bacteriol (2009) 1.15
Differential role of the interleukin-17 axis and neutrophils in resolution of inhalational anthrax. Infect Immun (2011) 1.07
Discriminating virulence mechanisms among Bacillus anthracis strains by using a murine subcutaneous infection model. Infect Immun (2008) 1.06
Interferon-inducible CXC chemokines directly contribute to host defense against inhalational anthrax in a murine model of infection. PLoS Pathog (2010) 1.03
Effect of CpG oligonucleotides on vaccine-induced B cell memory. J Immunol (2008) 1.00
Antimicrobial effects of interferon-inducible CXC chemokines against Bacillus anthracis spores and bacilli. Infect Immun (2009) 0.98
Cathelicidin administration protects mice from Bacillus anthracis spore challenge. J Immunol (2008) 0.95
Nod1/Nod2-mediated recognition plays a critical role in induction of adaptive immunity to anthrax after aerosol exposure. Infect Immun (2009) 0.95
Noncapsulated toxinogenic Bacillus anthracis presents a specific growth and dissemination pattern in naive and protective antigen-immune mice. Infect Immun (2007) 0.92
Human transferrin confers serum resistance against Bacillus anthracis. J Biol Chem (2010) 0.90
Bacillus anthracis interacts with plasmin(ogen) to evade C3b-dependent innate immunity. PLoS One (2011) 0.88
Systemic but not mucosal immunity induced by AVA prevents inhalational anthrax. Microbes Infect (2007) 0.87
Killed but metabolically active Bacillus anthracis vaccines induce broad and protective immunity against anthrax. Infect Immun (2009) 0.87
Anamnestic protective immunity to Bacillus anthracis is antibody mediated but independent of complement and Fc receptors. Infect Immun (2008) 0.85
Allelic variation on murine chromosome 11 modifies host inflammatory responses and resistance to Bacillus anthracis. PLoS Pathog (2011) 0.85
Activation of the classical complement pathway by Bacillus anthracis is the primary mechanism for spore phagocytosis and involves the spore surface protein BclA. J Immunol (2012) 0.82
Multigenic control and sex bias in host susceptibility to spore-induced pulmonary anthrax in mice. Infect Immun (2011) 0.79
MHC class II and non-MHC class II genes differentially influence humoral immunity to Bacillus anthracis lethal factor and protective antigen. Toxins (Basel) (2012) 0.77
Anthrax. Annu Rev Microbiol (2001) 9.69
Anthrax toxin. Annu Rev Cell Dev Biol (2003) 5.92
Differences in susceptibility of inbred mice to Bacillus anthracis. Infect Immun (1986) 3.78
The roles of anthrax toxin in pathogenesis. Curr Opin Microbiol (2004) 2.89
Non-toxigenic derivatives of the Ames strain of Bacillus anthracis are fully virulent for mice: role of plasmid pX02 and chromosome in strain-dependent virulence. Microb Pathog (1993) 2.06
Pathogenesis and genetic control of resistance to the Sterne strain of Bacillus anthracis. Microb Pathog (1988) 1.98
Cytokine response to infection with Bacillus anthracis spores. Infect Immun (2004) 1.86
Structure and function of anthrax toxin. Curr Top Microbiol Immunol (2002) 1.56
Immunoglobulin G monoclonal antibodies to Cryptococcus neoformans protect mice deficient in complement component C3. Infect Immun (2002) 1.24
Modulation of mouse endotoxic fever by complement. Infect Immun (2002) 0.93
Phase I clinical trial of a selective inhibitor of CYP17, abiraterone acetate, confirms that castration-resistant prostate cancer commonly remains hormone driven. J Clin Oncol (2008) 10.91
Selective inhibition of CYP17 with abiraterone acetate is highly active in the treatment of castration-resistant prostate cancer. J Clin Oncol (2009) 6.68
Phase I clinical trial of the CYP17 inhibitor abiraterone acetate demonstrating clinical activity in patients with castration-resistant prostate cancer who received prior ketoconazole therapy. J Clin Oncol (2010) 6.04
Significant and sustained antitumor activity in post-docetaxel, castration-resistant prostate cancer with the CYP17 inhibitor abiraterone acetate. J Clin Oncol (2010) 5.86
A fully integrated microfluidic genetic analysis system with sample-in-answer-out capability. Proc Natl Acad Sci U S A (2006) 3.03
Allele-specific silencing of dominant disease genes. Proc Natl Acad Sci U S A (2003) 3.00
Airborne transmission of Bordetella pertussis. J Infect Dis (2012) 2.34
Acellular pertussis vaccines protect against disease but fail to prevent infection and transmission in a nonhuman primate model. Proc Natl Acad Sci U S A (2013) 2.29
Direct determination of lipoprotein particle sizes and concentrations by ion mobility analysis. Clin Chem (2008) 2.27
Cytokine response to infection with Bacillus anthracis spores. Infect Immun (2004) 1.86
The Brucella abortus Cu,Zn superoxide dismutase is required for optimal resistance to oxidative killing by murine macrophages and wild-type virulence in experimentally infected mice. Infect Immun (2005) 1.55
Disease-related modifications in tau affect the interaction between Fyn and Tau. J Biol Chem (2005) 1.45
Nonhuman primate model of pertussis. Infect Immun (2012) 1.45
Interneuronal transfer of human tau between Lamprey central neurons in situ. J Alzheimers Dis (2010) 1.39
Murine aerosol challenge model of anthrax. Infect Immun (2007) 1.30
MyD88-dependent signaling contributes to protection following Bacillus anthracis spore challenge of mice: implications for Toll-like receptor signaling. Infect Immun (2005) 1.22
Macrophages release tumor necrosis factor alpha and interleukin-12 in response to intracellular Bacillus anthracis spores. Infect Immun (2004) 1.18
Chromatin condensation in terminally differentiating mouse erythroblasts does not involve special architectural proteins but depends on histone deacetylation. Chromosome Res (2009) 1.16
Role of anthrax toxins in dissemination, disease progression, and induction of protective adaptive immunity in the mouse aerosol challenge model. Infect Immun (2008) 1.14
Two motifs within the tau microtubule-binding domain mediate its association with the hsc70 molecular chaperone. J Neurosci Res (2008) 1.10
Role of C3a receptors, C5a receptors, and complement protein C6 deficiency in collagen antibody-induced arthritis in mice. J Immunol (2011) 1.10
Increase in tau tyrosine phosphorylation correlates with the formation of tau aggregates. Brain Res Mol Brain Res (2005) 1.08
Acetaminophen selectively suppresses peripheral prostaglandin E2 release and increases COX-2 gene expression in a clinical model of acute inflammation. Pain (2006) 1.00
Inflammatory cytokine response to Bacillus anthracis peptidoglycan requires phagocytosis and lysosomal trafficking. Infect Immun (2010) 0.99
Functional expression and localization of P-glycoprotein at the blood brain barrier. Microsc Res Tech (2002) 0.98
Tau impacts on growth-factor-stimulated actin remodeling. J Cell Sci (2007) 0.98
Tau potentiates nerve growth factor-induced mitogen-activated protein kinase signaling and neurite initiation without a requirement for microtubule binding. J Biol Chem (2010) 0.96
Advax-adjuvanted recombinant protective antigen provides protection against inhalational anthrax that is further enhanced by addition of murabutide adjuvant. Clin Vaccine Immunol (2014) 0.95
Nod1/Nod2-mediated recognition plays a critical role in induction of adaptive immunity to anthrax after aerosol exposure. Infect Immun (2009) 0.95
Analysis of bvgR expression in Bordetella pertussis. J Bacteriol (2003) 0.95
Evaluation of genetically inactivated alpha toxin for protection in multiple mouse models of Staphylococcus aureus infection. PLoS One (2013) 0.94
Dissemination bottleneck in a murine model of inhalational anthrax. Infect Immun (2012) 0.94
Epicutaneous model of community-acquired Staphylococcus aureus skin infections. Infect Immun (2013) 0.92
Pertussis pathogenesis--what we know and what we don't know. J Infect Dis (2014) 0.92
Phosphorylation of STAT3 serine-727 by cyclin-dependent kinase 1 is critical for nocodazole-induced mitotic arrest. Biochemistry (2006) 0.89
Anthrax protective antigen delivered by Salmonella enterica serovar Typhi Ty21a protects mice from a lethal anthrax spore challenge. Infect Immun (2009) 0.89
Quantification of the adenylate cyclase toxin of Bordetella pertussis in vitro and during respiratory infection. Infect Immun (2013) 0.88
Tau phosphorylation by cdk5 and Fyn in response to amyloid peptide Abeta (25-35): involvement of lipid rafts. J Alzheimers Dis (2009) 0.87
Role of catalase in the virulence of Brucella melitensis in pregnant goats. Vet Microbiol (2004) 0.87
Two distinct domains of protein 4.1 critical for assembly of functional nuclei in vitro. J Biol Chem (2002) 0.87
Systemic but not mucosal immunity induced by AVA prevents inhalational anthrax. Microbes Infect (2007) 0.87
Involvement of P-glycoprotein in the transport of saquinavir and indinavir in rat brain microvessel endothelial and microglia cell lines. Pharm Res (2004) 0.87
Spin labelling of Bacillus anthracis endospores: a model for in vivo tracking by EPR imaging. Free Radic Res (2008) 0.86
Anamnestic protective immunity to Bacillus anthracis is antibody mediated but independent of complement and Fc receptors. Infect Immun (2008) 0.85
Moraxella catarrhalis activates murine macrophages through multiple toll like receptors and has reduced clearance in lungs from TLR4 mutant mice. PLoS One (2012) 0.85
Two protein 4.1 domains essential for mitotic spindle and aster microtubule dynamics and organization in vitro. J Biol Chem (2004) 0.84
Stably luminescent Staphylococcus aureus clinical strains for use in bioluminescent imaging. PLoS One (2013) 0.84
Tau in MAPK activation. Front Neurol (2013) 0.83
The baboon model of pertussis: effective use and lessons for pertussis vaccines. Expert Rev Vaccines (2014) 0.83
Microtubule-associated protein tau in human prostate cancer cells: isoforms, phosphorylation, and interactions. J Cell Biochem (2009) 0.83
Tau protein binds single-stranded DNA sequence specifically--the proof obtained in vitro with non-equilibrium capillary electrophoresis of equilibrium mixtures. FEBS Lett (2005) 0.82
Exonic point mutations of human tau enhance its toxicity and cause characteristic changes in neuronal morphology, tau distribution and tau phosphorylation in the lamprey cellular model of tauopathy. J Alzheimers Dis (2009) 0.82
Activation of the vrg6 promoter of Bordetella pertussis by RisA. J Bacteriol (2005) 0.81
Reply to Domenech de Cellès et al.: Infection and transmission of pertussis in the baboon model. Proc Natl Acad Sci U S A (2014) 0.76
Counselors' and consumers' derived criteria for assessing the effectiveness of rehabilitation services. Int J Rehabil Res (2003) 0.75
Case series on aripiprazole and dopamine supersensitivity psychosis. Int Clin Psychopharmacol (2022) 0.75